Skip to main content

Menu

  • Our research
    • Breast Cancer
    • Gastrointestinal Cancers
    • Prostate Cancer
    • Uncommon Cancers
    • Novel Cancer Therapeutics
    • Targeted Physical Therapies
    • Digital - Capability, Informatics, Big Data, e-Health
    • Genotypes, Phenotypes and Cancer Evolution
  • About us
    • Our facilities
    • Working with us
    • Our collaborations
    • Acknowledging the NIHR BRC
    • Open Access policy
    • Staff profiles
  • Patient and public involvement and engagement
    • What is patient and public involvement and engagement at the BRC?
    • Getting involved: for patients and the public
    • Involving patients and the public: for researchers
    • Patient and public engagement events
    • BRC patient representatives: our experiences
    • Patient and public involvement and engagement: training resources
  • News & events
  • BRC Training Hub
    • BRC training opportunities
    • In profile: early career researchers
    • Fellowship funding
    • Training courses and events
    • Support for clinical researchers
    • Support for nurse, AHP & pharmacy researchers
    • Research support staff
    • Our partnerships
    • Training and education resources
    • COVID-19 resources
  • Advance magazine
  • Video library
    • Big Data: a guide for patients and the public
    • Patient and Public Involvement: Experience, Impact and Benefits
    • Patient and Public Involvement: The Importance of Diversity
    • What does the future hold for breast cancer? Session One
    • What does the future hold for breast cancer? Session Two
  • Search
Back to main site

Advance

The magazine for the UK's only Biomedical Research Centre dedicated to cancer

TOPIC: CLINICAL TRIALS
  • Drug development
  • Gene testing
  • Radiotherapy
  • Clinical trials
Browse by type
  • Forefront
  • Patient and public involvement
  • Case study
  • Expert voice
  • In profile
  • Q&A
  • Social
  • In numbers
  • News

Forefront

Rare talents
Forefront

Drug combination trial sees exciting results
Social

International Clinical Trials Day
Forefront

Offer gene tests to more breast cancer patients, says experts
Forefront

Meeting the complex needs of young patients

Breakthrough drugs approved for advanced breast cancer
Q&A

Q&A: The need for speed
Case study

Olaparib: the journey of a world-first drug
Forefront

PALOMA-3: Drug combination extends breast cancer control

New trial aims to treat gastro-oesophageal cancers
Forefront

Landmark trial for targeted drug

Listening to public opinion
Load more articles  

  • Home
  • Sitemap
  • Terms and conditions
  • Privacy and cookies
  • Accessibility
  • Contact

Copyright © 2021 Biomedical Research Centre for Cancer - a partnership between The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research. All rights reserved. The Royal Marsden ICR NIHR